on behalf of the Rescu Investigators* Background--It is believed that most sudden cardiac arrests (SCAs) in young people occur in previously healthy people with rare risk factors for sudden death. Few studies have investigated large populations with complete ascertainment. Our objective was to use multisource records to identify and classify all out-of-hospital cardiac arrests in the Greater Toronto Area (population 6.6 million) in people aged 2 to 45 years from 2009 to 2012.
S
udden cardiac arrest (SCA) in younger people, although rare, is often a highly publicized event, particularly among athletes. 1 These occurrences have a devastating impact on both the family and community, due to the perception that these individuals are "too young to die suddenly." 2 Because of various methodological differences between studies, reported incidence rates for sudden cardiac death (SCD) in younger people, which refers solely to nonsurvivors of SCA, can vary up to 6-fold, emphasizing the lack of clarity with respect to the true scope of this phenomenon. [3] [4] [5] In younger people, the cardiac causes of SCA are diverse and assumed to be most often caused by underlying potentially heritable cardiac diseases or "primary arrhythmia syndromes" with no identified risk factors. 6 In almost all studies of SCA in younger people, cardiomyopathies, "primary electrical disease," and premature coronary disease are the most frequently identified cardiac etiologies. [7] [8] [9] Yet the exact distribution of these etiologies differs substantially between studies. 10, 11 Moreover, it is generally assumed that these individuals have few comorbidities and that the cardiac disorder is the only relevant condition leading to the SCA event. This may not accurately reflect the spectrum of etiologies of SCA in this younger population. A more detailed examination of causes, circumstances, and potential triggers that contribute to the presentation of SCA in the younger population may address this confusion and help guide future studies in the prediction and prevention of SCA. Accurate assessment of these aspects requires a comprehensive evaluation of all SCAs within a geographic area. To date only 2 other studies have systematically tracked and described all young people with SCAs within defined geographic areas using multisource records. 12, 13 Both Meyer 13 and Jayaraman 12 used similar adjudication processes to classify and evaluate cohorts of young people (age <35) with SCAs from large US cities (populations %1-1.2 million), reporting on the incidence, etiologies, circumstances, and outcomes. Our study adds to these findings by comprehensively evaluating all out-of-hospital cardiac arrest (OHCA) events that had a 911 response in a larger urban area within the Greater Toronto Area of Ontario, Canada (population 6.6 million).
A population-based database interface of all OHCAs within the Greater Toronto Area (Rescu Epistry) has been successfully linked to detailed coroner and in-hospital records. 14 Previously, we found that the majority of OHCAs labeled as "presumed cardiac" in younger people were not primarily cardiac but occurred because of drug overdoses, acute noncardiac illnesses, or terminal diseases. 14 The current study expands the cohort of interest to include all cases of OHCA classified as "presumed cardiac" and, in addition, all motor vehicle accidents and drownings with documented cardiac arrest to align with prior literature. 15 Our objective was to systematically examine each of these SCA cases and describe the etiologies, circumstances, triggers, and characteristics in this expanded cohort.
Methods
The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Design
The methods used for this study have been described previously in detail. 14 In brief, this was an observational cohort study using data collected with a waiver of consent from the Rescu Epistry interface; Rescu Epistry is composed of data points from the Resuscitation Outcomes Consortium Epistry cardiac arrest database and the Strategies for Post Arrest Resuscitation Care database; the methodologies of which are described elsewhere. 16, 17 The study was approved by the St. Michael's Hospital Research Ethics Board (REB #10-105) and data were collected under a waiver of consent. Because of the sensitive nature of the data collected for this study, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to Katherine Allan at St. Michael's Hospital. Contact information is listed under address for correspondence.
Study Setting and Population
Rescu Epistry is a single web-based data management interface that links electronic data from Emergency Medical Services (EMS) and Fire Services; device data from monitors, defibrillators, and laptops; and clinical data from hospitals. The in-hospital data are entered into Rescu Epistry manually by trained data guardians after chart review with several builtin automated features to minimize errors. It captures all patients with OHCAs or trauma for which there was a 911 response occurring in the City of Toronto and adjacent
Clinical Perspective
What Is New?
• This study adds to the sudden cardiac arrest literature by describing in detail the etiologies, circumstances, triggers, and characteristics of a large urban, population-based sudden cardiac arrest cohort (both survivors and deceased) aged 2 to 45 years from 2009 to 2012.
• The results highlight that the underlying causes of sudden cardiac arrest in younger people are complex, often occurring in people with previously diagnosed cardiac diseases, and are associated with contributory factors including prescribed medications, recreational drugs, and a concomitant psychiatric history.
What Are the Clinical Implications?
• The high prevalence of cardiovascular disease risk factors among younger patients with sudden cardiac arrest highlights the importance of cardiac risk management aimed at those under age 45, in particular those aged 35 to 45.
• Furthermore, the high rates of psychiatric disease and prescribed central nervous system active drugs warrant caution with respect to the use of psychotropic therapies in patients diagnosed with mental illness and concomitant cardiac disease.
regions (Halton, Peel, Simcoe, Muskoka, York, and Durham) serving a population of 6.6 million people. This group of end users is collectively referred to as Toronto Regional RescuNET.
From the Rescu Epistry interface we identified OHCAs and traumas in people of all ages from January 1, 2009, to December 31, 2012 . From these, we identified OHCAs in people aged 2 to 45 years that were designated by trained data abstractors as presumed cardiac cause (ie, assumed to be attributable to an underlying cardiac disease) per the standardized Utstein criteria. 18 We also identified OHCAs in people aged 2 to 45 years that were designated as obvious, noncardiac causes, including those categorized as motor vehicle collisions or drownings, both with documented cardiac arrest, which could have been potential SCAs.
In our database search strategy, we included all motor vehicle collisions with documented cardiac arrest in either the driver or passenger. All other cases attributed to trauma including burns were excluded.
The lower age cutoff was chosen to exclude sudden infant death syndrome cases, as these are considered to be a different entity from SCA. 19 Age 45 was chosen as the upper age cutoff to maximize capture rates for heritable cardiac syndromes and prevent overlap with coronary artery disease. 1 
Data Collection
We used the following sources of information to adjudicate the cause of death and to collect past medical history, circumstances, and triggers on patients with SCA:
(1) ambulance call and fire reports; (2) in-hospital data; (3) medical certificates of death; (4) coroner investigative statements; (5) police reports; and (6) autopsies, toxicology, and molecular autopsy reports. The coroner investigative statement contains the deceased's personal information, medical history obtained from medical records, and a narrative summary including the circumstances, manner of death, and medical cause of death with contributory factors.
Autopsies are conducted by a forensic pathologist and follow a standardized protocol in which organs are examined both macroscopically and microscopically. When the death is suspected to be attributable to an underlying cardiac cause, the heart is sent to a specialized cardiovascular pathologist for further examination.
Standard protocols for toxicology testing were followed, including a general drug screen for ethanol and drugs of abuse and a comprehensive drug screen for 300 prescription and over-the-counter drugs. Testing is performed sequentially, such that if a drug is detected at a level considered to be either toxicologically significant or fatal, further testing is not performed. Toxicology was performed only as part of the autopsy, and we did not have toxicology results for survivors or those who died in-hospital without autopsy. Cases with toxicologic findings were reviewed by a toxicologist, coroner, and cardiac pathologist. Any SCAs for which the etiology was considered to be drug overdose on the basis of the drug concentrations and the clinical and autopsy findings were excluded from the study. In patients categorized as having SCA, none of the detected drug levels, including the few SCAs with "toxic" levels of drugs were deemed by toxicologists and cardiac pathologists to be solely causative of the SCA event.
Toxicology reports classify "toxic" drug levels on the basis of ranges reported in the literature; however, the actual effect on an individual is highly dependent on several factors including prior tolerance, type of drugs, dosage, and the like, all of which are taken into account by toxicologists and coroners when assigning cause of death. In such cases, the drug may have been considered contributory but not causative.
Review and Adjudication Process
Initially, all deceased people with OHCAs were matched to a coroner investigative statement and autopsy/toxicology report where available; all resuscitated people with OHCAs were matched to their in-hospital reports, where available. If there was a clear medical cause of death ascribed by the coroner or if there was a cause of death that was obviously noncardiac (ie, electrocution), the adjudication process was considered complete. OHCAs that were attributed to drug overdose; suicide; homicide; drowning; motor vehicle collisions; blunt, penetrating, or burn injury trauma; cancer; complex chronic care; acute noncardiac illnesses; and vascular noncardiac causes were excluded ( Figure 1 ). OHCAs that remained unmatched across source documents or that had unclear etiology (either cardiac or noncardiac) were also excluded.
In OHCAs for which the cause of death was unclear; or OHCAs with contributing factors, such as positive toxicology, and OHCAs with only EMS and in-hospital data (eg, survivors and people who died in-hospital without autopsy), a joint deliberation process ensued between the primary author and 2 additional experts (P.D., A.P.), using all available sources of information to assign cause of death, cardiac or noncardiac. OHCAs with contributing toxicology results were further reviewed with a coroner, cardiac pathologist, and toxicologist. For all cases, a decision was reached by consensus. The macroscopic and microscopic criteria used for different cardiac and noncardiac etiologies have been published previously.
as "presumed cardiac" when "there is evidence of a primary cardiac etiology or when an obvious non-cardiac cause for the OHCA has been ruled out. Obvious non-cardiac causes include: drowning, electrocution, trauma, anaphylaxis, drug overdose, other medical cause or asphyxia." Paramedics and trained data abstractors who assign this definition can also list contributing causes for an arrest, which are thought to contribute to the event but are not the direct cause (eg, patient was a known drug user and suspect drug poisoning but no direct evidence currently available). At the time of etiology assignment, paramedics have access to EMS data, and trained data abstractors have access to EMS and inhospital data. They do not have access to autopsy or toxicology findings.
Sudden cardiac arrest was defined as an abrupt collapse with documented loss of vital signs and attended by EMS in response to a 911 call. The etiology was considered to be cardiac only after the exclusion of SCAs attributable to vascular noncardiac disease, acute noncardiac illnesses, drug overdose, metabolic causes, or terminal disease. Cases could be witnessed or unwitnessed, with no time limit restrictions from the onset of the event to when the individual was found. SCA included both patients who did not survive (previously defined as SCD) and those successfully resuscitated.
Sudden unexplained deaths (SUDs) were those unexplained by preexisting disease after clinical investigation or without identifiable anatomic or toxicologic cause on autopsy. Physical activity level at the time of the event was defined as any form of physical activity that the individual was performing immediately before or within 1 hour of experiencing SCA. An estimated metabolic equivalent score was assigned to each type of physical activity based on the criteria described by Ainsworth et al. 20 Physical activity was classified into 4 groups: Rest (metabolic equivalent, 0.9-1.3), light activity (metabolic equivalent, 1.4-5.9), moderate activity (metabolic equivalent score ≥6), or unknown. Cardiac disease was based on documented evidence of a previous diagnosis of a cardiac disease or having been prescribed a cardiac medication, after chart review of multisource records including EMS/fire reports, in-hospital data, and autopsy reports when available.
Cardiovascular disease risk factors included diabetes mellitus, hyperlipidemia, hypertension (HTN), smoking, and obesity. Diabetes mellitus and hyperlipidemia were defined as such after observing a documented chart history or if the individual was prescribed a medication to treat those conditions. HTN and smoking were defined by a chart history, and obesity was defined as a body mass index ≥30 kg/m 2 .
Psychiatric disease: A patient with psychiatric disease was defined as such if (1) there was a documented previous diagnosis of psychiatric disease or (2) there was documented evidence that the patient was prescribed an antidepressant or antipsychotic medication. These details were obtained after chart review of multisource records, as described above.
Statistical Analysis
Descriptive statistics were used to assess the distribution of all variables. Continuous variables were summarized as means and standard deviations or medians and interquartiles, while categorical variables were summarized as counts and percentages. Cases were compared on the basis of 3 age groups: 2 to 24, 25 to 34, and 35 to 45, which is reflective of the age cutoffs used in similar studies. 7, 8 
Patient Characteristics
Three quarters of the SCA cohort (N=608) were male, with an average age of 35.4AE8.9 (Table 1) . Past medical history and prescribed medications were available in 582 of 608 (95.7%) and 504 of 608 (82.9%), respectively, of all SCAs. Prior to their SCA event, 395 of 582 (67.9%) of the entire cohort had a history of diagnosed cardiac disease or were prescribed a cardiac medication, and 320 of 582 (55%) were diagnosed with ≥1 cardiovascular disease risk factors. Just over 20% (117 of 582) were diagnosed with psychiatric disease. At the time of their SCA event, over 60% (61.7%; 311 of 504) had been prescribed ≥1 cardiac or central nervous system active medication, including cardiac (65.3%; 329 of 504), diabetic (10.3%; 52 of 504) and psychiatric (19.0%; 96 of 504).
Increasing Table 2 .
Detailed Causes of SCA Events
In the entire SCA cohort, (243 of 608) (40%) of cases were attributed to coronary heart disease (CHD), 174 of 608 (28.6%) attributed to structural diseases of the myocardium, 98 of 608 (16.1%) attributed to SUD, and 15 of 608 (2.5%) attributed to other cardiac causes (anomalous coronary arteries, congenital heart disease, and tamponade). In 78 of 608 (12.8%) of cases, the exact subtype of cardiac disease (either structural or arrhythmic but not CHD) remained (Figure 2) . In 14.1% of patients aged <35 years and 12.2% of patients aged ≥35 years, the exact subtype of cardiac disease (either structural or arrhythmic but not CHD) remained unspecified.
In the group aged <25 years, the most frequent causes of death were SUDs (36.6%) and structural diseases of the myocardium (40.2%) (Figure 2 ).
Males had a higher proportion of CHD in comparison to females (43.5% versus 28.5%; P=0.001), while proportions of structural diseases of the myocardium were higher in females versus males (26.7% males versus 34.7% females; P=0.06). Females had significantly higher proportions of SUDs compared with males (21.5% versus 14.4%; P=0.04) ( Table 3) .
The distribution of specific structural diseases of the myocardium for all SCAs stratified by age can be seen in Figure 3 . Younger age was associated with higher prevalence of arrhythmogenic right ventricular cardiomyopathy (ARVC; 7.3% ages 2-24 versus 1.5% ages 25-34 versus 1.3% ages 35-45) and HCM (6.1% ages 2-24 versus 0% ages 25-34 versus 0.8% ages 35-45). Sex-based comparisons can be found in Table 4 .
There were 140 SCAs (23.0%) attributable to potentially heritable cardiac diseases: 13 (2.1%) with ARVC, 21 (3.5%) with dilated cardiomyopathy, 8 (1.3%) with hypertrophic cardiomyopathy (HCM) and 98 (16.1%) with SUD. In contrast, acquired cardiac diseases such as CHD, sarcoidosis, myocarditis, congestive heart failure and cardiomyopathies due to HTN or valvular disease, constituted 52.8% (321 of 608) of the total SCA population.
Toxicology Results
Toxicology testing was performed in almost 60% (233 of 399) of autopsied SCAs, and 31.1% (124 of 399) had ≥1 drugs detected at any level ( Table 5 ). The most frequently detected central nervous system active drugs were ethanol (n=50), opioids (n=26), selective serotonin reuptake inhibitors (n=18) and cocaine/benzyolecgonine (n=16), benzodiazapines (n=16), and dopamine antagonists (n=13), with most drugs detected at or below therapeutic levels (Table 6 ).
In the SUD group (n=98), (31 of 98) (31.6%) had a positive toxicology, with alcohol and opioids (n=12) detected most frequently, followed by antidepressants and antipsychotics (n=11) and over-the-counter prescription drugs (n=8).
Despite some SCAs having toxic levels of drugs detected postmortem, the toxicologists and cardiac pathologists agreed that the cause of death in these individuals was primarily attributable to a cardiac etiology, and the significant or toxic drug levels were considered contributory but not causative.
Circumstances and Triggers
Most SCA events occurred at home and during rest (Table 7) . Patients aged <35 with SCA of cardiac cause more often had Table 8 .
Discussion
This study is one of a few to describe in detail the distribution of adjudicated underlying cardiac causes, circumstances, triggers, and characteristics of a large, population-based cohort of younger patients with SCA, where all EMS-attended cardiac arrests in a large urban area were evaluated. The main finding is that most SCA events were not completely "unexpected" in that they occurred in people who were previously diagnosed with conditions known to be associated with sudden death, such as cardiac and psychiatric disease. In contrast to other studies, potentially heritable structural cardiac diseases such as HCM, ARVC, and dilated cardiomyopathy constituted <10% of the combined total cohort, while rates of SCAs attributable to SUDs were comparable to other recent studies in this area. 7, 9, 12 Our data suggest that, in younger people, SCA events do not mainly occur in "healthy individuals," as has been reported by other studies in this area. 4, 9, 21 We observed that 67.9% of SCA events in people aged <45 years occurred in patients with a past cardiac medical history and in 20.1% of those with a past psychiatric history. Comparisons with other SCD studies in younger people are difficult, as few report this level of detail. 4, 9, 21 Two large population-based SCD autopsy studies from Denmark reported that up to 24% of people aged <35 years with SCD had a reported previous medical history, 4 while in a larger, older cohort (age <50 years), 58.2% had a past medical history. 9 The overall rate of HTN (24%) among our SCA cohort was comparable to that reported for the general Canadian population 22 ; however, compared with agematched cohorts, the rates of HTN and smoking were substantially higher among older (age >35 years) SCA cases (HTN: 32.4% ours versus 10.3% reported) and smoking (31.3% ours versus 18.9% reported). 23, 24 Moreover, the rate of diabetes mellitus (13.4%) in our study was twice as high as what has been reported in the general Canadian population. 25 Similar findings of higher rates of diabetes mellitus, HTN, and obesity among patients with SCA aged 5 to 34 years were observed by the Oregon SUDS (Sudden Unexpected Death Figure 2 . Age distribution of cardiac etiologies in sudden cardiac arrests. Other includes congenital heart disease, anomalous coronary arteries, and tamponade. Cardiac disease unspecified includes cases in whom the etiology was considered to be cardiac, either structural or arrhythmic, but not coronary heart disease. Cardiac disease unspecified includes patients in whom the etiology was considered to be cardiac, either structural or arrhythmic, but not coronary heart disease.
Study) group, with 58% of patients having ≥1 cardiovascular disease risk factors, suggesting that these risk factors may play a larger role in SCA among younger adults than was previously thought.
12
Our study is the only North American study to report on the prevalence of a psychiatric history in younger patients with SCA within a population-based cohort. 26, 27 A Danish study reported that 20% of young people (age <50 years) with SCDs and 14% of sudden noncardiac deaths had a past medical history of psychiatric disease. 26 We observed that a history of depression and psychosis were more frequent than expected among SCAs compared with the general Canadian Moreover, in our study, one third of SCA patients were prescribed ≥1 psychotropic medications (defined here as antidepressants, antipsychotics, opioids, benzodiazapines, and non-benzodiazapine hypnotics), which could have contributed to their event. In addition, the main central nervous system active drugs detected at autopsy in our cohort following toxicology testing were drugs of abuse, including opioids, ethanol, and cocaine, while the 2 main psychotropic medications detected were antipsychotics and antidepressants. The potential proarrhythmic properties of psychotropic drugs such as antipsychotics 32 or opioids 33 could have induced a fatal arrhythmia in these patients through prolongation of the QT interval. A study by the Oregon SUDS group observed that among SCA cases in people aged ≥18 years from the general population, antipsychotic drugs were significant and independent determinants of pulseless electrical activity. 34 It is widely believed that potentially heritable structural cardiac diseases such as HCM, ARVC, and dilated cardiomyopathy are the most frequent causes of SCD among those aged <35 years, 11 while in adults aged >35 years, CHD accounts for up to 70% to 75% of all SCD events. 35 In our study, we observed similar rates of CHD and SUDs compared with other North American studies among younger people, 7, 12, 13 including a recent study from the Oregon SUDS group. 12 They observed that SUDs (31%), CHD (22%), and HCM (14%) were the most frequent SCA etiologies in those aged 5 to 34 years. However, our rates of potentially inheritable cardiomyopathies such as HCM, ARVC, and dilated cardiomyopathy (42 of 608; 6.9% combined) were substantially lower. The most likely explanations for these discrepancies are the differing case ascertainment strategies and patient inclusion criteria used between studies, as was highlighted in a recent meta-analysis on HCM as a cause of SCD among younger people. 36 In contrast to Jayaraman et al, who used traditional, time-based SCD definitions to identify their cases, we used the underlying etiology with no time-based restrictions to classify SCAs, thus increasing the overall denominator. Furthermore, although there are recommended guidelines for performing autopsies, few jurisdictions have adopted these standardized approaches. 36 Within our catchment area, forensic autopsies are performed using a standardized protocol, and any SCD cases with a diagnosis of a heritable cardiac disease, including HCM, are reviewed by a specialized cardiac pathologist. Finally, although autopsies are recommended for all SCD cases, 37 autopsy rates among most SCD studies range between 12% and 75%. 9, 38 A strength of our study is that our autopsy rates are among some of the highest reported in the published literature, following the POST SCD (Postmortem Systematic Investigation of Sudden Cardiac Death) group in San Francisco. 39 The proportion of SCD individuals diagnosed on autopsy with an "acquired" heart disease such as hypertensive cardiomyopathy (HTN-CM) in our cohort, is higher than what has been reported elsewhere. 4, 9, 40 A Finnish study observed a rate of HTN-CM at 15.5%, while recent studies in Denmark reported HTN-CM rates of 5.7% in individuals aged 1 to 35 years and 7.7% in those aged 1 to 49 years. 4, 9, 40 A diagnosis of HTN-CM is based on both macroscopic and microscopic findings in the heart in the absence of any other disease (eg, coronary artery disease or valvular disease), and a history of HTN or evidence of renovascular hypertensive changes at autopsy. 9, 41 Alternatively, as this study involves a populationbased sample that is derived from a large and ethnically diverse population in Ontario, population diversity could account for the observed differences in etiologies. 42 Interestingly, in individuals aged 2 to 34 years, CHD accounted for 16.4% of all SCA events and over half of SCA events in the 35 to 45 age group. The high prevalence of CHD and HTN-CM among young patients with SCA highlights the importance of cardiovascular disease risk management in much younger patients.
Limitations
In our jurisdiction, toxicology is performed in 2 situations:
(1) when cause of death is not evident from macroscopic or microscopic investigation and/or (2) when there is an indication that drugs may have contributed to the cause of death. If there is a clear cause of death, toxicology testing is usually not performed unless drugs are considered to be contributory. Only 60% of all autopsied cases received toxicology testing. We were not able to report the toxicology levels of the rest of the autopsied cases and the nonautopsied cases, including survivors. Thus, we may have overestimated the number of patients with SCA with contributory levels of medications on board, particularly in survivors. Ascertainment of past medical history and prescribed medications was not possible for 4.3% and 17.1% of our population, respectively; therefore, there is a potential for bias.
Despite a comprehensive review of each case, there are inherent limitations in current autopsy protocols and coroner diagnoses that can complicate the determination of a specific disorder as the cause for the SCD event. However, a lack of autopsy information was counterbalanced by the high availability of coroner investigative statements, from which we were able to extract important information about the cause and circumstances of death.
Conclusions
Our results highlight that the underlying causes of SCA in younger people are complex, often occurring in people with previously diagnosed cardiovascular diseases and cardiovascular disease risk factors, and are associated with contributory factors including prescribed medications, recreational drugs, and a concomitant psychiatric history.
